Takeda To Market Wyeth's Pneumococcal Vaccine For Children In Japan
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical will market Wyeth's Prevnar, pneumococcal 7-valent conjugate vaccine for infants and toddlers in Japan